Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.
about
Clinical application of a 3D ultrasound-guided prostate biopsy systemESUR prostate MR guidelines 2012Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizersUltrasonic enhancement of drug penetration in solid tumors.Visualizing the prostate gland by MR imaging in young and old miceApparent diffusion coefficient values of normal testis and variations with ageDiagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies.Diffusion-weighted MRI and its role in prostate cancer.Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressivenessReducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical settingEADC Values in Diagnosis of Renal Lesions by 3.0 T Diffusion-Weighted Magnetic Resonance Imaging: Compared with the ADC ValuesMultiparametric magnetic resonance imaging of prostate cancer.Imaging in prostate cancer staging: present role and future perspectives.The role of 1.5 Tesla magnetic resonance imaging in staging prostate cancer.Role of high-field MR in studies of localized prostate cancer.One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified "all-in-one" imaging approach?Preoperative mp-MRI of the prostate provides little information about staging of prostate carcinoma in daily clinical practice.The optimal timing of post-prostate biopsy magnetic resonance imaging to guide nerve-sparing surgery.Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.PI-RADS version 2: Evaluation of diffusion-weighted imaging interpretation between B = 1000 and B = 1500 s/mm(2).Accuracy of high b-value diffusion-weighted MRI for prostate cancer detection: a meta-analysis.Prostate cancer in magnetic resonance imaging: diagnostic utilities of spectroscopic sequences.Oncological outcomes following robotic-assisted radical prostatectomy in a multiracial Asian population.Prostate diffusion-weighted imaging at 3T: effect of intravenous gadobutrol administration.Segmented diffusion-weighted imaging of the prostate: Application to transperineal in-bore 3T MR image-guided targeted biopsy.Diffusion-weighted magnetic resonance imaging for the evaluation of prostate cancer: optimal B value at 3T.Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate CancerRe: diffusion-weighted imaging of prostate cancer: how can we use it accurately?Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging.The diagnostic accuracy of high b-value diffusion- and T2-weighted imaging for the detection of prostate cancer: a meta-analysis.Triexponential function analysis of diffusion-weighted MRI for diagnosing prostate cancer.What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T?Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.Discrimination of local recurrence after radical prostatectomy: value of diffusion-weighted magnetic resonance imaging.Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection
P2860
Q24608010-C5B10BC8-79A5-42AC-AC6B-73469962F9EDQ24620926-1A0A426C-BB7F-4753-8F07-25D1CA3978EBQ26738622-B1A1470C-C47F-4723-9F51-FA613259F1C3Q30450492-435A8FA5-0CE5-4FC0-8B94-756D0B2D1D7EQ30597000-1F0F76FA-37AD-45ED-B306-AD74B5A729ABQ33621475-ED9CBD6B-8625-4CBF-8689-2BFA42BBECDDQ34678985-54DB853C-7FBF-4459-946A-686AEAA39566Q34742733-948C2AE1-27A8-4375-82A4-048579DCF10AQ34995967-4F430628-1E59-4627-9FBF-CC1AEFF0DF65Q35164071-35B26999-E4F5-4BFE-B026-EF42DDE53F26Q36182439-39115E05-B291-475C-A49C-51004EA63D2CQ36649498-14335E94-88BA-40CA-A1B1-E5771040C6A1Q36761055-2C1ED611-F272-45F1-A2C0-13C37049099FQ37979650-BF288C54-D524-43B6-AF79-C3F4BCED7541Q38086840-FC7C138D-E35E-4086-86C1-2264546495D6Q38109111-DA714D98-0D88-4600-9D76-ACC2FBCD3F4EQ38174546-70398076-0052-498E-8545-E07E544FB0CCQ38272447-DC867536-F206-4B59-A573-47718F1E4428Q38283233-C2EAF674-6077-428D-92B7-B9801B4609D0Q38537545-80E1CB97-AB24-4F2E-A1CE-130B3FE7EE92Q38613875-BA94B1DF-F406-48F5-8F8D-06B6F4DE6C7AQ38855337-B9679F1A-E5E1-4229-853E-0EDA29B31588Q40078453-6633AF88-C40B-4D30-A96F-3FF5F66CDF98Q40359501-C7050420-6AF9-405F-B8AC-5F4F7B856DD3Q40647574-4F1D6758-2DE4-4257-8848-FB3DA00375A3Q41551186-D6AB2175-669D-44F6-AB80-ACD80DEFB0B5Q42112215-0FFADF9A-8996-42C2-8898-B35FED4556A0Q42374568-FB9CA077-BA60-41F2-9A9F-913FC8D43C71Q42611422-397FE51A-7C61-4595-A79B-BB92FD3AFAEDQ43529342-7E3FBF7F-8820-4C9E-9AE3-C0A11D13A45CQ44557996-86D8D581-2225-46A5-8CDD-8236C63FE408Q45396642-D51BDCB9-78BF-463B-9DDF-057CC35E8328Q47410159-0A92A9BF-1D82-4864-9514-203CB95B89FBQ50891703-9F29C5BC-22BA-4E4C-AA82-AFFD63EA219BQ53198801-371E893D-386F-4F01-8656-C706276143C7Q53359183-21FE27D2-5CBD-4A87-B1E9-16697E7ECCE4Q54956785-E3448DAC-4F38-40F8-95ED-181FE6167BEFQ57784098-11B9241A-B5F0-4312-8C00-0D1F224BDE71
P2860
Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.
@en
Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.
@nl
type
label
Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.
@en
Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.
@nl
prefLabel
Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.
@en
Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.
@nl
P2093
P356
P1476
Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.
@en
P2093
Bohyun Kim
Byung Kwan Park
Chan Kyo Kim
P304
P356
10.2214/AJR.09.3654
P407
P577
2010-06-01T00:00:00Z